BackMellanox Technologies, Overview

Mellanox Technologies, Total Liabilities

Latest total liabilities for MLNX: $500M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$495.65M
36.59% YoYΔ $132.79M vs prior year quarter

Peer trimmed avg / median

Loading

Mellanox Technologies, Total Liabilities History

Loading

Mellanox Technologies, vs. peers: Total Liabilities Comparison

Loading

Mellanox Technologies, Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Mellanox Technologies, (MLNX) FAQ

The latest total liabilities for MLNX is $500M as of March 2020. That compares with $360M in the prior-year period — up 36.6% year over year. Investors often review this figure alongside Mellanox Technologies,'s historical trend and sector peers before judging valuation or financial health.

Over the past year, MLNX's total liabilities moved from $360M to $500M — a 36.6% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Mellanox Technologies,'s operating scale or balance-sheet position.

A total liabilities figure of $500M for MLNX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting MLNX's total liabilities ($500M), review year-over-year change from $360M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Mellanox Technologies,'s total liabilities against similar Technology names. You can also browse sector and industry screens on Stockcircle for a broader set of Technology companies and their key multiples and fundamentals.